Stock Events

Stock Events

Silence Therapeutics (SLN) Q3 2024 Earnings

15AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.18

-0.12

-0.06

0

Details

Expected EPS

-0.0375813175

Actual EPS

-0.0467791

Surprise EPS

-0.01

Surprise Percent

+24.47%

Description

Silence Therapeutics (SLN) has reported earnings of -0.0467791 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.